Skip to main content
  • Home
  • Scheme Overview

HDFC Pharma and Healthcare Fund - IDCW Option

Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 04-10-2023
Asset Class: Equity
Benchmark: S&P BSE Healthcare
Expense Ratio: 2.34% As on (30-04-2024)
Status: Open Ended Schemes
Minimum Investment: 100.0
Minimum Topup: 100.0
Total Assets: 830.67 Cr As on (30-04-2024)
Turn over:
NAV (₹): 12.601
₹ 0.16 ( 1.2459%)
as on 13-05-2024
CAGR Since Inception - 26.45%
S&P BSE Healthcare - 14.72%

Fund Managers

Dhruv Muchhal, Nikhil Mathur


Investment Objective

The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.

PERFORMANCE of HDFC Pharma and Healthcare Fund - IDCW Option

Scheme Performance (%) Data as on - 13-05-2024

1-Year Ret (%) 3-Yrs Ret (%) 5-Yrs Ret (%) 10-Yrs Ret (%) Since Launch Ret (%)
HDFC Pharma and Healthcare Fund - IDCW Option - - - - 26.45
S&P BSE Healthcare TRI 52.62 13.64 22.27 13.49 14.72
Equity: Sectoral-Pharma and Healthcare 49.8 13.77 24.0 15.43 18.05

RETURNS CALCULATOR for HDFC Pharma and Healthcare Fund - IDCW Option

Growth of 10000 In SIP (Fund vs Benchmark)

Amount :
Period :
Start :
End :

Growth of 10000 In LUMPSUM (Fund vs Benchmark)

Amount :
Start :

Rolling Returns

Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.

Key Performance and Risk Statistics of HDFC Pharma and Healthcare Fund - IDCW Option

Key Statistics Volatility Sharpe Ratio Alpha Beta Yield to Maturity Average Maturity
HDFC Pharma and Healthcare Fund - IDCW Option - - - - - -
Equity: Sectoral-Pharma and Healthcare - - - - - -

PEER COMPARISION

Scheme Name Launch
Date
1-Year
Ret (%)
2-Yrs
Ret (%)
3-Yrs
Ret (%)
5-Yrs
Ret (%)
10-Yrs
Ret (%)
HDFC Pharma and Healthcare Fund IDCW 04-10-2023 0.0 0.0 0.0 0.0 0.0
ICICI Pru Pharma Healthcare and Diagnostics PHD Fund Cum 25-07-2018 55.0 29.64 15.69 25.9 0.0
ABSL Pharma and Healthcare Reg Gr 05-07-2019 52.88 25.59 13.13 0.0 0.0
Tata India Pharma & Healthcare Reg Gr 28-12-2015 52.0 26.92 15.19 23.78 0.0
Nippon India Pharma Fund Gr Gr 01-06-2004 51.07 26.64 14.04 24.63 17.08
SBI HEALTHCARE Opportunities Reg Gr 14-07-1999 50.51 30.09 15.22 23.78 15.38
UTI Healthcare Reg Gr 05-08-2005 49.57 24.5 12.17 22.55 13.83
Mirae Asset Healthcare Reg Gr 10-07-2018 48.28 23.52 13.63 25.33 0.0
DSP Healthcare Reg Gr 05-11-2018 48.09 28.28 15.5 26.33 0.0
LIC MF Healthcare Fund Reg Gr 22-02-2019 46.2 20.29 9.32 19.68 0.0

Asset Allocation (%)

PORTFOLIO ANALYSIS of HDFC Pharma and Healthcare Fund - IDCW Option

Portfolio as on

Top 10 Sectors in portfolio (%)

Top 10 Stocks in portfolio (%)

AMC partners we work with